CLINICOPATHOLOGICAL AND MOLECULAR CORRELATES OF HER2 EXPRESSION, PIK3CA MUTATIONS AND EBV INFECTION INVOLVED IN THE PI3K-AKT PATHWAY IN GASTRIC CANCER

被引：0
|
作者：
Sukawa, Y. [1 ]
Yamamoto, H. [1 ]
Kunimoto, H. [1 ]
Nosho, K. [1 ]
Suzuki, H. [1 ,2 ]
Adachi, Y. [1 ]
Nobuoka, T. [3 ]
Kawayama, M. [4 ]
Mikami, M. [4 ]
Matsuno, T. [5 ]
Hasegawa, T. [6 ]
Hirata, K. [3 ]
Shinomura, Y. [1 ]
机构：
[1] Sapporo Med Univ, Sch Med, Dept Internal Med 1, Sapporo, Hokkaido, Japan
[2] Sapporo Med Univ, Dept Mol Biol, Sch Med, Sapporo, Hokkaido, Japan
[3] Sapporo Med Univ, Dept Surg 1, Sch Med, Sapporo, Hokkaido, Japan
[4] JR Sapporo Hosp, Dept Gastroenterol, Sapporo, Hokkaido, Japan
[5] Sapporo Gekakinen Hosp, Dept Surg, Sapporo, Hokkaido, Japan
[6] Sapporo Med Univ Hosp, Dept Surg Pathol, Sapporo, Hokkaido, Japan
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：84 / 84
页数：1
相关论文
共 50 条
  • [41] PIK3CA mutations in HER2-positive breast cancer: an ongoing conundrum
    Goel, S.
    Krop, I. E.
    ANNALS OF ONCOLOGY, 2016, 27 (08) : 1368 - 1372
  • [42] Clinicopathological significance of PI3K, Akt and survivin expression in gastric cancer
    Gu, Yongjuan
    Jin, Shidai
    Wang, Feng
    Hua, Yibin
    Yang, Li
    Shu, Yongqian
    Zhang, Zhihong
    Guo, Renhua
    BIOMEDICINE & PHARMACOTHERAPY, 2014, 68 (04) : 471 - 475
  • [43] CRISPLD1 promotes gastric cancer progression by regulating the Ca2+/PI3K-AKT signaling pathway
    Hu, Liqiang
    Shi, Jianghua
    Zhu, Zichen
    Lu, Xuemei
    Jiang, Huibo
    Yu, Hanyang
    Liu, Hao
    Chen, Wei
    HELIYON, 2024, 10 (05)
  • [44] PIK3CA and PIK3R1 mutations in cancer: from the mechanism of activation to PI3K targeted therapies
    Rzepecka, Iwona K.
    Tysarowski, Andrzej
    ONCOLOGY IN CLINICAL PRACTICE, 2024,
  • [45] Combined inhibition of HER2 and VEGFR synergistically improves therapeutic efficacy via PI3K-AKT pathway in advanced ovarian cancer
    Weisong Li
    Kai Zhang
    Wenjun Wang
    Yuanyuan Liu
    Jianming Huang
    Meihong Zheng
    Ling Li
    Xinyu Zhang
    Minjuan Xu
    Guofang Chen
    Liefeng Wang
    Shuyong Zhang
    Journal of Experimental & Clinical Cancer Research, 43
  • [46] Combined inhibition of HER2 and VEGFR synergistically improves therapeutic efficacy via PI3K-AKT pathway in advanced ovarian cancer
    Li, Weisong
    Zhang, Kai
    Wang, Wenjun
    Liu, Yuanyuan
    Huang, Jianming
    Zheng, Meihong
    Li, Ling
    Zhang, Xinyu
    Xu, Minjuan
    Chen, Guofang
    Wang, Liefeng
    Zhang, Shuyong
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2024, 43 (01)
  • [47] PIK3CA copy number aberration and activation of the PI3K-AKT-mTOR pathway in varied disease states of penile cancer
    Adimonye, Anthony
    Stankiewicz, Elzbieta
    La-Touche, Susannah
    Kudahetti, Sakunthala
    Trevisan, Giorgia
    Tinwell, Brendan
    Corbishley, Cathy
    Lu, Yong-Jie
    Watkin, Nick
    Berney, Daniel
    PLOS ONE, 2018, 13 (06):
  • [48] Bcl-2 Is Involved in Cardiac Hypertrophy throu PI3K-Akt Pathway
    Meng, Xianwei
    Cui, Jun
    He, Guibin
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [49] Neuregulin-1 expression correlates with sensitivity to the PI3K inhibitor, GDC-0032, outside of PIK3CA mutations in head and neck cancer
    Savage, Heidi M.
    O'Brien, Carol
    Yauch, Bob
    Settleman, Jeff
    Lackner, Mark R.
    Wilson, Timothy R.
    CANCER RESEARCH, 2014, 74 (19)
  • [50] Somatic frameshift mutation in PIK3CA causes CLOVES syndrome by provoking PI3K/AKT/mTOR pathway
    Yan, Wei
    Zhang, Bin
    Wang, Huijun
    Mo, Ran
    Jiang, Xingyuan
    Qin, Wen
    Ma, Lin
    Lin, Zhimiao
    HEREDITAS, 2021, 158 (01)
12345